Device Week, 8 July 2019: Omron Healthcare Update; New Watchman Data

In this edition of Device Week, Medtech Insight’s Marion Webb reviews her interview with Omron Healthcare CEO Ranndy Kellogg at the recent AdvaMed conference in San Francisco. Reed Miller discusses the latest cost-effectiveness study of Boston Scientific’s Watchman left-atrial appendage closure device. For more information on Medtech Insight and to start a free trial, click here: http://bit.ly/2FWqEWl Medtech Insight articles addressing topics discussed in this episode. Expert Panel Discusses Impact Of Stricter US, EU Data Privacy Laws On Medtech Industry http://bit.ly/2XydvJI CES 2016: Consumer and Medical Devices Come Together in Digital Health http://bit.ly/30fZeCG Long-Term Analysis Shows Boston Scientific’s Watchman Device Saves Money http://bit.ly/2Xr4KAD Global Device Approvals, Weekly Snapshot: FDA Approves Bard’s Venovo Stent; Abbott’s MitraClip Gets Indication-Expansion; Boston Scientific’s Watchman FLX Earns CE Mark http://bit.ly/2LaaVYb Starts & Stops: Boston Scientific Completes Enrollment In Precision SCS, Watchman FLX, Lotus TAVR, Ranger II SFA Studies http://bit.ly/2xxRRdo